Dr. John Chabot: Treating Peritoneal Mesothelioma in New York

Quick Facts

Primary Location:
New York-Presbyterian Hospital/Columbia University Medical Center
Expertise:
Gastrointestinal Cancer
Sarcoma
Speciality:
Surgery
Gender:
Male
Language:
English
Med School:
Geisel School of Medicine at Dartmouth

Get to Know Dr. John A. Chabot

Surgical oncologist Dr. John A. Chabot has spent more than three decades at Columbia University working toward the prevention, treatment and cure of several abdominal cancers, including peritoneal mesothelioma.

Chabot was instrumental in bringing the cytoreductive surgery and heated intraperitoneal chemotherapy combination to the Herbert Irving Cancer Center to advance the treatment of peritoneal diseases.

He works closely with top mesothelioma doctors Dr. Robert Taub, director of the Mesothelioma Center, and Dr. Michael Kluger, another peritoneal mesothelioma specialist.

Chabot serves as executive director of the Columbia Pancreas Center and division chief of GI/endocrine surgery at nearby New York-Presbyterian Hospital.

In treating patients with mesothelioma, he leads a multidisciplinary team of oncologists, radiologists and pathologists in utilizing the most up-to-date therapies available. He takes pride in fully educating patients and responding to challenges associated with advancing technology.

Contact Dr. John A. Chabot

212-305-9468

Specialties of Dr. John A. Chabot

Pancreatic cancer
Peritoneal mesothelioma
Liver resection surgery
Liver cancer
Sarcoma
Laparoscopic cholecystectomy
Gastrointestinal cancer
Thyroid cancer

Dr. John A. Chabot’s Experience and Medical Education

Columbia University Herbert Irving Comprehensive Cancer Center
New York-Presbyterian/Columbia University Medical Center
Geisel School of Medicine at Dartmouth
New York-Presbyterian/Columbia University Medical Center (Residency)
Dartmouth-Hitchcock Medical Center (Fellowship)

Awards and Other Recognitions

New York Magazine Top Doctors
Practitioner of the Year, Society of Practitioners of CUMC
Surgery for Excellence in Teaching and Mentoring Award, General Surgery Residents, NYP/Columbia
Thomas C. King Resident Teaching Award
Habif Scholar

Publications of Dr. John Chabot

DiNorcia, J. et al. (2010. October 14). One Hundred Thirty Resections for Pancreatic Neuroendocrine Tumor: Evaluating the Impact of Minimally Invasive and Parenchyma-Sparing Techniques. Journal of Gastrointestinal Surgery.
Chabot, J. et al. (2010, April 20). Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer. Journal of Clinical Oncology.
Li, J. et al. (2010, April 11). Updates of Adjuvant Therapy in Pancreatic Cancer: Where Are We and Where Are We Going? Journal of the Pancreas.